Konstantinos Andrikopoulos serves as Executive at RXI PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Konstantinos Andrikopoulos has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 20, 2010 involved receiving (via award) 5,750 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 20, 2010 | RXII | $0 | Award | 5,750 | $N/A | Discretionary |
Konstantinos Andrikopoulos currently holds 5,750 shares of RXI PHARMACEUTICALS CORP (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Konstantinos Andrikopoulos has been a net neutral trader of RXII stock. They have purchased $0 and sold $0 worth of shares.
Konstantinos Andrikopoulos's most recent insider trade was on Jan 20, 2010, when they sold 5,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted